GlaxoSmithKline Pharmaceuticals informs about certificate

02 Apr 2024 Evaluate

As required under Clause 7(3) of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the certificate jointly issued by Company and Company Registrar and Share Transfer Agent - Kfin Technologies for year ended 31st March 2024.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2650.85 31.45 (1.20%)
25-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.80
Dr. Reddys Lab 1306.60
Cipla 1345.70
Zydus Lifesciences 919.40
Lupin 2292.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×